{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:47:46Z","timestamp":1777016866340,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical University","doi-asserted-by":"publisher","award":["Byycx23029"],"award-info":[{"award-number":["Byycx23029"]}],"id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2023AH051976"],"award-info":[{"award-number":["2023AH051976"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brazilian Journal of Otorhinolaryngology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bjorl.2025.101739","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:46:48Z","timestamp":1764348408000},"page":"101739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5"],"prefix":"10.1016","volume":"92","author":[{"given":"Anchi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongrong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0637-4437","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5294-0906","authenticated-orcid":false,"given":"Qianqian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjorl.2025.101739_bib0005","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.bjorl.2025.101739_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1259331","article-title":"Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijlh.14211","article-title":"MicroRNA-based therapies: revolutionizing the treatment of acute myeloid leukemia","volume":"46","author":"Chandraprabha Vineetha","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113891","article-title":"Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer","volume":"434","author":"Yadav","year":"2024","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bjorl.2025.101739_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1017","article-title":"LncRNA DLX6-AS1 increases the expression of HIF-1\u03b1 and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p","volume":"8","author":"Yang","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.bjorl.2025.101739_bib0030","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.3390\/cancers15225351","article-title":"Circular RNA from Tyrosylprotein Sulfotransferase 2 Gene Inhibits Cisplatin Sensitivity in Head and Neck Squamous Cell Carcinoma by Sponging miR-770-5p and Interacting with Nucleolin","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bjorl.2025.101739_bib0035","first-page":"533","article-title":"Oncogenic miR-106b-5p promotes cisplatin resistance in triple-negative breast cancer by targeting GDF11","volume":"39","author":"Zhou","year":"2024","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173105","article-title":"miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells","volume":"878","author":"Jin","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12957-022-02546-w","article-title":"Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells","volume":"20","author":"Zhou","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41419-019-1850-4","article-title":"Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p\/SLC1A5 axis","volume":"10","author":"Zhuang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bjorl.2025.101739_bib0055","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000662","article-title":"Serum exosome-derived microRNA-193a-5p and miR-381-3p regulate adenosine 5\u2019-monophosphate-activated protein kinase\/transforming growth factor Beta\/Smad2\/3 signaling pathway and promote fibrogenesis","volume":"15","author":"Wang","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0060","first-page":"835","article-title":"MicroRNA-508-3p regulates the proliferation of human lung cancer cells by targeting G1 to S phase transition 1 (GSPT1) protein","volume":"70","author":"Chen","year":"2023","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14715\/cmb\/2023.69.8.12","article-title":"Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting","volume":"69","author":"Dong","year":"2023","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.bjorl.2025.101739_bib0070","doi-asserted-by":"crossref","DOI":"10.1080\/21623945.2023.2293273","article-title":"Leptin secreted by adipocytes promotes EMT transition and endometrial cancer progression via the JAK2\/STAT3 signalling pathway","volume":"13","author":"Shen","year":"2024","journal-title":"Adipocyte"},{"key":"10.1016\/j.bjorl.2025.101739_bib0075","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.21037\/jtd.2019.10.56","article-title":"Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs)","volume":"11","author":"Wu","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.bjorl.2025.101739_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117560","article-title":"Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells","volume":"97","author":"Zhang","year":"2024","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bjorl.2025.101739_bib0085","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bjorl.2025.101739_bib0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bjorl.2025.101739_bib0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.bjorl.2025.101739_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168907","article-title":"GLUT1 and ASCT2 as predictors for prognosis of hepatocellular carcinoma","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bjorl.2025.101739_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.70","article-title":"ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma","volume":"6","author":"Marshall","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bjorl.2025.101739_bib0110","article-title":"Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924\/SLC1A5 signaling","volume":"36","author":"Liu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.bjorl.2025.101739_bib0115","article-title":"Ag120-mediated inhibition of ASCT2-dependent glutamine transport has an anti-tumor effect on colorectal cancer cells","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0120","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.3390\/ijms24086945","article-title":"Therapeutic potential of tumor metabolic reprogramming in triple-negative breast cancer","volume":"24","author":"Munk\u00e1csy","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bjorl.2025.101739_bib0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ccr.2010.08.017","article-title":"Cancer metabolism: is glutamine sweeter than glucose","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bjorl.2025.101739_bib0130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s13277-015-4671-9","article-title":"Glutamine at focus: versatile roles in cancer","volume":"37","author":"De Vitto","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bjorl.2025.101739_bib0135","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/1759-7714.15257","article-title":"CircCPA4 induces ASCT2 expression to promote tumor property of non-small cell lung cancer cells in a miR-145-5p-dependent manner","volume":"15","author":"Zhang","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.bjorl.2025.101739_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101764","article-title":"Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in Renal Cell Carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression","volume":"77","author":"Yang","year":"2023","journal-title":"Transpl Immunol"}],"container-title":["Brazilian Journal of Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869425001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1808869425001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:17:46Z","timestamp":1777015066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1808869425001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1808869425001831"],"URL":"https:\/\/doi.org\/10.1016\/j.bjorl.2025.101739","relation":{},"ISSN":["1808-8694"],"issn-type":[{"value":"1808-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5","name":"articletitle","label":"Article Title"},{"value":"Brazilian Journal of Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjorl.2025.101739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Otorrinolaringologia e Cirurgia C\u00e9rvico-Facial. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101739"}}